Kedokteran & Kesehatan editorial
Open AccessOA2023
Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options
Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a major public health threat due to its high mortality and limited treatment options. This review summarizes key virulence factors, molecular epidemiology, and the latest antimicrobial alternatives for CRKP infections.
T. Karampatakis; K. Tsergouli; P. Behzadi· Antibiotics· 2023· DOI 10.3390/antibiotics12020234
The core problem
Klebsiella pneumoniae is a Gram-negative opportunistic pathogen responsible for a variety of community and hospital infections. Infections caused by carbapenem-resistant K. pneumoniae (CRKP) constitute a major threat for public health and are strongly associated with high rates of mortality, especially in immunocompromised and critically ill patients. The emergence of CRKP is primarily driven by carbapenemase production, particularly K. pneumoniae carbapenemase (KPC) and metallo-β-lactamase (MBL). Understanding the molecular mechanisms of resistance is crucial for selecting appropriate antimicrobial therapy. This review aims to highlight the virulence factors and molecular pathogenesis of CRKP and provide recent updates on the molecular epidemiology and antimicrobial treatment options.
Innovation
The authors conducted a comprehensive review of the literature on CRKP, focusing on virulence factors, molecular epidemiology, and treatment options. The review synthesizes data from studies on the pathogenicity of K. pneumoniae, the mechanisms of carbapenem resistance, and the efficacy of various antimicrobial agents. The selection of studies was based on relevance to the topic, with an emphasis on recent publications describing novel therapeutic options. The review covers both established and emerging treatment modalities, including plazomicin, eravacycline, cefiderocol, temocillin, ceftolozane–tazobactam, imipenem–cilastatin/relebactam, meropenem–vaborbactam, ceftazidime–avibactam, and aztreonam–avibactam.
Introduction
Klebsiella pneumoniae is a Gram-negative opportunistic pathogen responsible for a variety of community and hospital infections. Infections caused by carbapenem-resistant K. pneumoniae (CRKP) constitute a major threat for public health and are strongly associated with high rates of mortality, especially in immunocompromised and critically ill patients. The emergence of CRKP is primarily driven by carbapenemase production, particularly K. pneumoniae carbapenemase (KPC) and metallo-β-lactamase (MBL). Understanding the molecular mechanisms of resistance is crucial for selecting appropriate antimicrobial therapy. This review aims to highlight the virulence factors and molecular pathogenesis of CRKP and provide recent updates on the molecular epidemiology and antimicrobial treatment options.
Why it matters
The review underscores the critical importance of understanding the molecular mechanisms of CRKP resistance for guiding antimicrobial selection. The virulence factors of K. pneumoniae, such as fimbriae, capsule, LPS, and siderophores, play a significant role in the pathogenesis of infections, and targeting these factors could be a potential therapeutic strategy. The emergence of carbapenemases, particularly KPC and MBL, necessitates the use of alternative agents. The newer antimicrobials listed offer hope for treating CRKP infections, but their efficacy may vary depending on the resistance mechanism. For instance, ceftazidime–avibactam is effective against KPC-producing strains but not against MBL-producing strains, whereas aztreonam–avibactam may be useful for MBL-producing strains. The review highlights the need for rapid diagnostic tests to identify the resistance mechanism and guide therapy. Additionally, infection control measures are essential to curb the spread of CRKP. The authors conclude that a multifaceted approach combining novel antimicrobials, diagnostics, and infection control is necessary to combat CRKP.
Who should read this
Pembaca Research Digest dan praktisi rumpun ini.
Opening member content…